AGL Stock Alert: agilon health CEO Resigns; agilon Suspends Full Year 2025 Earnings Guidance – Kehoe Law Firm, P.C. Investigating Potential Securities Claims

PHILADELPHIA, PA / ACCESS Newswire / August 5, 2025 / Kehoe Law Firm, P.C. is investigating potential violations of federal securities laws and claims on behalf of investors of agilon health, inc. ("agilon" or the "Company") (NYSE:AGL).

A logo for a law firmDescription automatically generated

On August 4, 2025, Steven J. Sell resigned as agilon’s CEO and President, and the Company reported it "suspend[ed] its full year 2025 earnings guidance due to leadership change, ongoing implementation of performance visibility initiatives as well as dynamic market conditions."

On this news, agilon’s stock price was down more than 33% pre-market on August 5, 2025.

Investors of agilon stock with financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, myarnoff@kehoelawfirm.com, info@kehoelawfirm.com, to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.

ABOUT KEHOE LAW FIRM, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

This press release may constitute attorney advertising.

SOURCE: Kehoe Law Firm, P.C.

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_467805337/2457/2025-08-05T07:47:53

Scroll to Top